World's first intra-nasal vaccine for COVID developed by India gets CDSCO nod
The intra-nasal vaccine for COVID received approval under restricted Use in emergency situations for ages 18 and above for primary two dose schedule, homologous booster doses, Union minister Dr Jitendra Singh said.
Source: ifp.co.in